Masao Matsuoka Selected Research

T-Cell Leukemia (Leukemia, T Cell)

3/2021	A regulatory element in the 3'-untranslated region of CEBPA is associated with myeloid/NK/T-cell leukemia.
1/2019	Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities In Vitro and In Vivo.
12/2018	Long Noncoding RNA ANRIL Supports Proliferation of Adult T-Cell Leukemia Cells through Cooperation with EZH2.
1/2016	Enhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody.
4/2015	Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.
4/2015	Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors.
9/2012	Human T-cell leukemia virus type 1 (HTLV-1) bZIP factor requires cellular transcription factor JunD to upregulate HTLV-1 antisense transcription from the 3' long terminal repeat.
1/2012	HTLV-2 APH-2 expression is correlated with proviral load but APH-2 does not promote lymphocytosis.
7/2010	APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo.
8/2009	HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masao Matsuoka Research Topics

Disease

34	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 11/2022 - 01/2002
26	Infections 01/2021 - 04/2002
18	Neoplasms (Cancer) 06/2022 - 06/2003
18	T-Cell Leukemia (Leukemia, T Cell) 03/2021 - 08/2002
10	Lymphoma (Lymphomas) 06/2022 - 06/2003
8	Carcinogenesis 12/2018 - 08/2005
6	Multiple Myeloma 01/2022 - 01/2019
4	Inflammation (Inflammations) 01/2020 - 08/2015
4	HIV Infections (HIV Infection) 12/2019 - 04/2002
4	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 01/2018 - 08/2002
3	Spinal Cord Diseases 01/2019 - 08/2002
3	T-Cell Lymphoma (Lymphoma, T Cell) 10/2015 - 08/2002
2	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2022 - 07/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 07/2017 - 07/2017
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2013 - 10/2008
2	Virus Diseases (Viral Diseases) 11/2012 - 09/2012
1	Amyloidosis 01/2022
1	Diarrhea 11/2021
1	Immunoglobulin Light-chain Amyloidosis 11/2021
1	Myeloid Sarcoma (Chloroma) 08/2021
1	Hematologic Neoplasms (Hematological Malignancy) 07/2021
1	Hypoxia (Hypoxemia) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018
1	Cytopenia 07/2018

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2007
6	Messenger RNA (mRNA)IBA 01/2021 - 01/2006
6	Pharmaceutical PreparationsIBA 08/2016 - 09/2006
5	CytokinesIBA 01/2020 - 08/2002
5	LigandsIBA 01/2019 - 09/2006
4	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2008
4	6H- 6- imino- (2,3,4,5- tetrahydropyrimido)(1,2- c)- (1,3)benzothiazineIBA 04/2015 - 09/2012
4	DNA (Deoxyribonucleic Acid)IBA 12/2009 - 04/2004
3	mogamulizumabIBA 03/2022 - 01/2018
3	ParaffinIBA 01/2022 - 11/2016
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2006
3	Bortezomib (Velcade)FDA Link 11/2021 - 07/2004
3	Macrophage Colony-Stimulating FactorIBA 01/2019 - 01/2002
3	IminesIBA 04/2015 - 11/2012
3	NucleosidesIBA 12/2009 - 01/2007
3	Reverse Transcriptase InhibitorsIBA 12/2009 - 11/2006
2	Formaldehyde (Formol)FDA Link 01/2022 - 01/2019
2	fludarabineIBA 07/2021 - 08/2012
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2010
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 08/2002
2	Cell Adhesion Molecule-1IBA 12/2018 - 07/2017
2	InterleukinsIBA 01/2018 - 08/2002
2	Immune Checkpoint ProteinsIBA 07/2017 - 11/2016
2	MucinsIBA 07/2017 - 11/2016
2	Immunoglobulins (Immunoglobulin)IBA 07/2017 - 11/2016
2	Anti-HIV Agents (AIDS Drugs)IBA 10/2015 - 04/2002
2	InterferonsIBA 10/2015 - 08/2015
2	Anti-Retroviral Agents (Antiretroviral Agents)IBA 04/2015 - 11/2012
2	pyrimidineIBA 04/2015 - 04/2015
2	Oncogene Proteins (Oncogene Protein)IBA 04/2015 - 04/2007
2	Tenofovir (Viread)FDA Link 04/2013 - 11/2006
2	Zidovudine (Retrovir)FDA LinkGeneric 04/2013 - 11/2006
2	Peptides (Polypeptides)IBA 12/2010 - 01/2008
2	EnzymesIBA 12/2009 - 01/2008
2	AntigensIBA 08/2009 - 04/2002
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2009 - 04/2004
2	Viral ProteinsIBA 08/2005 - 08/2003
1	LipidsIBA 06/2022
1	PD 128042IBA 06/2022
1	CholesterolIBA 06/2022
1	dimorpholinethiuram disulfideIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Lenalidomide (CC 5013)FDA Link 01/2022
1	daratumumabIBA 01/2022
1	Busulfan (Busulfex)FDA Link 07/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2021
1	Methotrexate (Mexate)FDA LinkGeneric 07/2021
1	ElementsIBA 03/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	Histidine (L-Histidine)FDA Link 01/2021
1	bis(5'-adenosyl)triphosphataseIBA 01/2021
1	Positive Transcriptional Elongation Factor BIBA 01/2021
1	CC ChemokinesIBA 01/2021
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2020
1	Single-Chain AntibodiesIBA 12/2019
1	EpitopesIBA 12/2019
1	Factor XIII (Coagulation Factor XIII)IBA 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019
1	Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link 01/2019
1	Polycomb Repressive Complex 1IBA 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	Long Noncoding RNAIBA 12/2018
1	Familial apoceruloplasmin deficiencyIBA 07/2018
1	CopperIBA 07/2018

Therapy/Procedure

11	Therapeutics 11/2021 - 04/2002
6	Drug Therapy (Chemotherapy) 01/2022 - 11/2011
3	Hematopoietic Stem Cell Transplantation 08/2021 - 06/2008
2	Transplantation 11/2022 - 07/2021
2	Immunotherapy 07/2017 - 11/2016
2	Molecular Targeted Therapy 06/2014 - 11/2011
2	Highly Active Antiretroviral Therapy (HAART) 01/2008 - 04/2002
1	Cell Transplantation 03/2022
1	Stem Cell Transplantation 01/2021
1	Blood Transfusion (Blood Transfusions) 01/2019